Published in Thromb Haemost on March 01, 2008
Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood (2009) 2.00
Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica (2009) 1.65
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk. Sci Transl Med (2014) 1.42
Two disparate ligand-binding sites in the human P2Y1 receptor. Nature (2015) 1.25
Intestinal alkaline phosphatase regulates protective surface microclimate pH in rat duodenum. J Physiol (2009) 1.24
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J (2011) 1.23
Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects. Eur J Clin Pharmacol (2010) 1.13
Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem (2009) 1.10
Resolvin E1 regulates adenosine diphosphate activation of human platelets. Arterioscler Thromb Vasc Biol (2010) 1.09
A further insight into the sialome of the tropical bont tick, Amblyomma variegatum. BMC Genomics (2011) 1.06
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. Stem Cells Dev (2012) 1.01
Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol (2011) 0.99
An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets. Blood (2011) 0.99
The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets. J Biol Chem (2008) 0.93
ARF6-dependent regulation of P2Y receptor traffic and function in human platelets. PLoS One (2012) 0.92
Anti-platelet therapy: ADP receptor antagonists. Br J Clin Pharmacol (2011) 0.92
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques. PLoS One (2010) 0.89
Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. Mol Biol Cell (2010) 0.88
Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives. Bioorg Med Chem Lett (2009) 0.87
Determinants to optimize response to clopidogrel in acute coronary syndrome. Pharmgenomics Pers Med (2010) 0.87
The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413. Purinergic Signal (2012) 0.85
Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay. Transfus Med Hemother (2013) 0.84
P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window. Trends Cardiovasc Med (2009) 0.84
Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity. Sci Rep (2014) 0.84
Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets. J Mol Signal (2011) 0.82
The Molecular Mechanism of P2Y1 Receptor Activation. Angew Chem Int Ed Engl (2016) 0.81
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Vasc Health Risk Manag (2009) 0.81
Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing. Purinergic Signal (2011) 0.81
Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases. Sci Rep (2015) 0.80
Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. Psychosom Med (2009) 0.80
Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation. Br J Haematol (2011) 0.80
Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel. Br J Pharmacol (2012) 0.79
Adenosine and blood platelets. Purinergic Signal (2011) 0.79
Blood cells: an historical account of the roles of purinergic signalling. Purinergic Signal (2015) 0.78
Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation. PLoS One (2012) 0.77
Editorial: Platelets as Immune Cells in Physiology and Immunopathology. Front Immunol (2015) 0.77
Purinergic control of inflammation and thrombosis: Role of P2X1 receptors. Comput Struct Biotechnol J (2014) 0.76
Group VIB calcium-independent phospholipase A2 (iPLA2γ) regulates platelet activation, hemostasis and thrombosis in mice. PLoS One (2014) 0.76
Physiological level of norepinephrine increases adenine nucleotides hydrolysis in rat blood serum. Purinergic Signal (2011) 0.76
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin. Br J Pharmacol (2012) 0.76
In silico Approach for Anti-Thrombosis Drug Discovery: P2Y1R Structure-Based TCMs Screening. Front Pharmacol (2017) 0.75
Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood (2016) 0.75
Ligand binding to a G protein-coupled receptor captured in a mass spectrometer. Sci Adv (2017) 0.75
Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods. Evid Based Complement Alternat Med (2016) 0.75
Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism? PLoS One (2014) 0.75
The platelet: life on the razor's edge between hemorrhage and thrombosis. Transfusion (2014) 0.75
Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release. Purinergic Signal (2015) 0.75
P2X and P2Y receptor signaling in red blood cells. Front Mol Biosci (2015) 0.75
Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome. J Thromb Thrombolysis (2017) 0.75